Moreover, we reported that both harmine and harmaline inhibited the TCDD-mediated induction of the carcinogen-activating enzyme, CYP1A1 in human hepatoma HepG2 cells through transcriptional and posttranslational mechanisms [9, 10]. This evidence concerns the gene CYP1A1 and hepatocellular carcinoma.